InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Hoppenot Herve, Chairman & CEO. Officer active across 2 companies, notably INCYTE CORP. Cumulatively, 18 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €17.1m. History available since 2 July 2021. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hoppenot Herve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
3,032 shares0Ordinary SharesSEC:0001596492-26-000002:0
2,843 shares@ US$96.700.9% of flowCommon StockSEC:0001596492-25-000010:0
187,500 shares@ US$105.4669.5% of flowCommon StockSEC:0001596492-25-000008:0
12,500 shares0Ordinary SharesSEC:0001415889-25-024100:0
4,961 shares@ US$69.984.0% of flowCommon StockSEC:0000879169-25-000079:0
42,769 shares@ US$68.1734.2% of flowCommon StockSEC:0000879169-25-000071:0
6,016 shares0Common StockSEC:0001628280-25-033513:0
66,899 shares0Common StockSEC:0001628280-25-016570:0
41,025 shares0Common StockSEC:0000879169-24-000133:0
41,723 shares@ US$59.0248.1% of flowCommon StockSEC:0000879169-24-000116:0
41,577 shares0Common StockSEC:0000879169-24-000060:0
43,184 shares0Common StockSEC:0001209191-23-042547:0
43,467 shares@ US$62.0851.9% of flowCommon StockSEC:0001209191-23-041510:0
29,196 shares0Common StockSEC:0001209191-23-004564:0
60,433 shares0Common StockSEC:0001209191-22-041071:0
2,227 shares0Common StockSEC:0001209191-21-066406:0
44,264 shares0Common StockSEC:0001209191-21-045789:0
10,442 sharesCommon StockSEC:0001209191-16-090537:0
18 of 18 declarations
About Hoppenot Herve
Hoppenot Herve is Président-Directeur Général and has 18 filings in total. Across the 18 sampled filings, the period runs from 2016-01-08 to 2026-01-06, with 0 in purchases and 17129209 in sales, mainly at INCYTE CORP and, as director, at BICYCLE THERAPEUTICS plc.
